LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.73 | 17.25 | 3 | 1290 | 0.0023 | -0.2450 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.73 | 17.25 | 1225 | 1290 | 0.9495 | 0.9834 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.73 | 17.25 | 2 | 1290 | 0.0016 | -0.2926 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.73 | 17.25 | 1483 | 1290 | 1.1494 | 1.0452 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.70 | 17.25 | 3 | 1466 | 0.0020 | -0.2388 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.70 | 17.25 | 1286 | 1466 | 0.8768 | 0.9594 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.70 | 17.25 | 3 | 1466 | 0.0020 | -0.2388 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 26.70 | 17.25 | 1592 | 1466 | 1.0854 | 1.0257 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.67 | 17.25 | 9 | 1653 | 0.0054 | -0.0941 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.67 | 17.25 | 1399 | 1653 | 0.8463 | 0.9499 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.67 | 17.25 | 6 | 1653 | 0.0036 | -0.1482 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 28.67 | 17.25 | 1729 | 1653 | 1.0459 | 1.0137 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 30.64 | 17.25 | 8 | 1887 | 0.0042 | -0.1073 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 30.64 | 17.25 | 1534 | 1887 | 0.8128 | 0.9397 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 30.64 | 17.25 | 4 | 1887 | 0.0021 | -0.1941 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 30.64 | 17.25 | 1872 | 1887 | 0.9918 | 0.9976 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 32.61 | 17.25 | 4 | 2136 | 0.0019 | -0.1896 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 32.61 | 17.25 | 1699 | 2136 | 0.7953 | 0.9352 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 32.61 | 17.25 | 8 | 2136 | 0.0037 | -0.1047 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 32.61 | 17.25 | 2055 | 2136 | 0.9619 | 0.9889 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 34.57 | 17.25 | 5 | 2523 | 0.0020 | -0.1582 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 34.57 | 17.25 | 1850 | 2523 | 0.7332 | 0.9155 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 34.57 | 17.25 | 3 | 2523 | 0.0012 | -0.2159 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 34.57 | 17.25 | 2245 | 2523 | 0.8898 | 0.9678 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | H17 |